{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:01:32Z","timestamp":1784779292950,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05428-0","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:06:21Z","timestamp":1778569581000},"page":"16437-16449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance signal detection of central nervous system demyelinating diseases following human papillomavirus vaccination: data mining and signal analysis based on the VAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Nan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leimin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"5428_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.jsps.2022.10.001","volume":"30","author":"OA Almadani","year":"2022","unstructured":"Almadani OA, Alshammari TM (2022) Vaccine adverse event reporting system (VAERS): evaluation of 31 years of reports and pandemics\u2019 impact. Saudi Pharm J 30:1725\u20131735. https:\/\/doi.org\/10.1016\/j.jsps.2022.10.001","journal-title":"Saudi Pharm J"},{"key":"5428_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2194772","volume":"19","author":"M Alsanafi","year":"2023","unstructured":"Alsanafi M, Salim NA, Sallam M (2023) Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs. Hum Vaccin Immunother 19:2194772. https:\/\/doi.org\/10.1080\/21645515.2023.2194772","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2315653","volume":"20","author":"J An","year":"2024","unstructured":"An J, Liu Y, Ma Y, Jiao YZ, Liang XF, Jin N et al (2024) Real-world data of China: analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 2021. Hum Vaccin Immunother 20:2315653. https:\/\/doi.org\/10.1080\/21645515.2024.2315653","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013479","volume":"2019","author":"H Bergman","year":"2019","unstructured":"Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V et al (2019) Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst Rev 2019:CD013479. https:\/\/doi.org\/10.1002\/14651858.CD013479","journal-title":"Cochrane Database Syst Rev"},{"key":"5428_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","volume":"144","author":"L Bruni","year":"2021","unstructured":"Bruni L, Saura-L\u00e1zaro A, Montoliu A, Brotons M, Alemany L, Diallo MS et al (2021) HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med 144:106399. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106399","journal-title":"Prev Med"},{"key":"5428_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101183","author":"M Caldarelli","year":"2024","unstructured":"Caldarelli M, Rio P, Giambra V, Gasbarrini A, Gambassi G, Cianci R (2024) ASIA syndrome: state-of-the-art and future perspectives. Vaccines Basel. https:\/\/doi.org\/10.3390\/vaccines12101183","journal-title":"Vaccines Basel"},{"key":"5428_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti E, Correale J (2021) Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation 18:208. https:\/\/doi.org\/10.1186\/s12974-021-02249-1","journal-title":"J Neuroinflammation"},{"key":"5428_CR8","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-790-2020","volume":"54","author":"NS Carvalho","year":"2021","unstructured":"Carvalho NS, Silva R, Val I, Bazzo ML, Silveira M (2021) Brazilian protocol for sexually transmitted infections 2020: human papillomavirus (HPV) infection. Rev Soc Bras Med Trop 54:e2020790. https:\/\/doi.org\/10.1590\/0037-8682-790-2020","journal-title":"Rev Soc Bras Med Trop"},{"key":"5428_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000726","volume":"3","author":"RM Casey","year":"2024","unstructured":"Casey RM, Akaba H, Hyde TB, Bloem P (2024) Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. BMJ Med 3:e000726. https:\/\/doi.org\/10.1136\/bmjmed-2023-000726","journal-title":"BMJ Med"},{"key":"5428_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/09513590.2013.852531","volume":"30","author":"C Castelo-Branco","year":"2014","unstructured":"Castelo-Branco C, Soveral I (2014) The immune system and aging: a review. Gynecol Endocrinol 30:16\u201322. https:\/\/doi.org\/10.3109\/09513590.2013.852531","journal-title":"Gynecol Endocrinol"},{"key":"5428_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fnana.2019.00095","volume":"13","author":"V Cipollini","year":"2019","unstructured":"Cipollini V, Anrather J, Orzi F, Iadecola C (2019) Th17 and cognitive impairment: possible mechanisms of action. Front Neuroanat 13:95. https:\/\/doi.org\/10.3389\/fnana.2019.00095","journal-title":"Front Neuroanat"},{"key":"5428_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466875","volume":"15","author":"X Dai","year":"2024","unstructured":"Dai X, Yu K, Chang Y, Hou Y (2024) Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases. Front Pharmacol 15:1466875. https:\/\/doi.org\/10.3389\/fphar.2024.1466875","journal-title":"Front Pharmacol"},{"key":"5428_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105168","volume":"115","author":"G Diana","year":"2021","unstructured":"Diana G, Corica C (2021) Human papilloma virus vaccine and prevention of head and neck cancer, what is the current evidence. Oral Oncol. 115:105168. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105168","journal-title":"Oral Oncol."},{"key":"5428_CR14","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H et al (2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. The Journal of Immunology 183:6186\u20136197. https:\/\/doi.org\/10.4049\/jimmunol.0901474","journal-title":"The Journal of Immunology"},{"key":"5428_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/cid\/ciz887","volume":"71","author":"R Donken","year":"2020","unstructured":"Donken R, Dobson S, Marty KD, Cook D, Sauvageau C, Gilca V et al (2020) Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: follow-up of a randomized clinical trial. Clin. Infect. Dis. 71:1022\u20131029. https:\/\/doi.org\/10.1093\/cid\/ciz887","journal-title":"Clin. Infect. Dis."},{"key":"5428_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anplas.2006.04.003","volume":"52","author":"T Dumont","year":"2007","unstructured":"Dumont T, Simon E, Stricker M, Kahn JL, Chassagne JF (2007) [Facial fat: descriptive and functional anatomy, from a review of literature and dissections of 10 split-faces]. Ann. Chir. Plast. Esthet. 52:51\u201361. https:\/\/doi.org\/10.1016\/j.anplas.2006.04.003","journal-title":"Ann. Chir. Plast. Esthet."},{"key":"5428_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2022.151284","volume":"38","author":"L Elst","year":"2022","unstructured":"Elst L, Albersen M (2022) HPV vaccination: does it have a role in preventing penile cancer and other preneoplastic lesions. Semin Oncol Nurs 38:151284. https:\/\/doi.org\/10.1016\/j.soncn.2022.151284","journal-title":"Semin Oncol Nurs"},{"key":"5428_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000031","volume":"1","author":"M Fern\u00e1ndez-Fournier","year":"2014","unstructured":"Fern\u00e1ndez-Fournier M, D\u00edaz de Ter\u00e1n J, Barranco AT, Puertas I (2014) Early cervical myelitis after human papilloma virus vaccination. Neurology(R) neuroimmunology & neuroinflammation 1:e31. https:\/\/doi.org\/10.1212\/NXI.0000000000000031","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"5428_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","volume":"41","author":"S Fischinger","year":"2019","unstructured":"Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G (2019) Sex differences in vaccine-induced humoral immunity. Semin Immunopathol 41:239\u2013249. https:\/\/doi.org\/10.1007\/s00281-018-0726-5","journal-title":"Semin Immunopathol"},{"key":"5428_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/21645515.2016.1168952","volume":"12","author":"J Gee","year":"2016","unstructured":"Gee J, Weinbaum C, Sukumaran L, Markowitz LE (2016) Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States. Hum Vaccin Immunother 12:1406\u20131417. https:\/\/doi.org\/10.1080\/21645515.2016.1168952","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR21","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.15167\/2421-4248\/jpmh2018.59.3.998","volume":"59","author":"C Genovese","year":"2018","unstructured":"Genovese C, LA Fauci V, Squeri A, Trimarchi G, Squeri R (2018) HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature. J Prev Med Hyg 59:E194\u2013E199. https:\/\/doi.org\/10.15167\/2421-4248\/jpmh2018.59.3.998","journal-title":"J Prev Med Hyg"},{"key":"5428_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-023-00547-2","volume":"18","author":"L Han","year":"2023","unstructured":"Han L, Zhang B (2023) Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect. Infect Agent Cancer 18:66. https:\/\/doi.org\/10.1186\/s13027-023-00547-2","journal-title":"Infect Agent Cancer"},{"key":"5428_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/21645515.2018.1526585","volume":"15","author":"T Hasan","year":"2019","unstructured":"Hasan T, Kumari K, Devi SC, Handa J, Rehman T, Ansari NA et al (2019) Osmolytes in vaccine production, flocculation and storage: a critical review. Hum Vaccin Immunother 15:514\u2013525. https:\/\/doi.org\/10.1080\/21645515.2018.1526585","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneuroim.2012.01.010","volume":"244","author":"V Herder","year":"2012","unstructured":"Herder V, Hansmann F, Stangel M, Schaudien D, Rohn K, Baumg\u00e4rtner W et al (2012) Cuprizone inhibits demyelinating leukomyelitis by reducing immune responses without virus exacerbation in an infectious model of multiple sclerosis. J Neuroimmunol 244:84\u201393. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.01.010","journal-title":"J Neuroimmunol"},{"key":"5428_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051044","volume":"10","author":"B Huber","year":"2021","unstructured":"Huber B, Wang JW, Roden R, Kirnbauer R (2021) RG1-VLP and other L2-based, broad-spectrum HPV vaccine candidates. J Clin Med 10:1044. https:\/\/doi.org\/10.3390\/jcm10051044","journal-title":"J Clin Med"},{"key":"5428_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1096\/fj.09-141978","volume":"24","author":"J Huppert","year":"2010","unstructured":"Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E et al (2010) Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 24:1023\u20131034. https:\/\/doi.org\/10.1096\/fj.09-141978","journal-title":"FASEB J"},{"key":"5428_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","volume":"33","author":"JK Iskander","year":"2004","unstructured":"Iskander JK, Miller ER, Chen RT (2004) The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety. Pediatr Ann 33:599\u2013606. https:\/\/doi.org\/10.3928\/0090-4481-20040901-11","journal-title":"Pediatr Ann"},{"key":"5428_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/v16050680","volume":"16","author":"JE Jensen","year":"2024","unstructured":"Jensen JE, Becker GL, Jackson JB, Rysavy MB (2024) Human Papillomavirus and associated cancers: a review. Viruses 16:050680. https:\/\/doi.org\/10.3390\/v16050680","journal-title":"Viruses"},{"key":"5428_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67627-0","volume":"14","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Shen Y, Zhou Q, Zhu H (2024) Unveiling the adverse events of Nusinersen in spinal muscular atrophy management based on FAERS database. Sci Rep 14:17138. https:\/\/doi.org\/10.1038\/s41598-024-67627-0","journal-title":"Sci Rep"},{"key":"5428_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121413","volume":"9","author":"S Kamolratanakul","year":"2021","unstructured":"Kamolratanakul S, Pitisuttithum P (2021) Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines (Basel) 9:1413. https:\/\/doi.org\/10.3390\/vaccines9121413","journal-title":"Vaccines (Basel)"},{"key":"5428_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.47936\/encephalitis.2021.00136","volume":"2","author":"M Lee","year":"2022","unstructured":"Lee M, Ahn MY, Roh H (2022) A case of acute disseminated encephalomyelitis following human papillomavirus quadrivalent vaccination. Encephalitis (Seoul, Korea) 2:54\u201357. https:\/\/doi.org\/10.47936\/encephalitis.2021.00136","journal-title":"Encephalitis (Seoul, Korea)"},{"key":"5428_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0974-3","volume":"17","author":"L Li","year":"2017","unstructured":"Li L, Sun L, Du R, Zheng Y, Dai F, Ma Q et al (2017) Application of the 2016 diagnostic approach for autoimmune encephalitis from Lancet Neurology to Chinese patients. BMC Neurol 17:195. https:\/\/doi.org\/10.1186\/s12883-017-0974-3","journal-title":"BMC Neurol"},{"key":"5428_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112750","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Zhao C, Zhao Y, Li J, Wei L (2023) Immunogenicity, efficacy, and safety of human papillomavirus vaccine: data from China. Front Immunol 14:1112750. https:\/\/doi.org\/10.3389\/fimmu.2023.1112750","journal-title":"Front Immunol"},{"key":"5428_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010102","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Sah R, Muhammad K, Waheed Y (2023) Tracking HPV infection, associated cancer development, and recent treatment efforts-a comprehensive review. Vaccines 11:0102. https:\/\/doi.org\/10.3390\/vaccines11010102","journal-title":"Vaccines"},{"key":"5428_CR35","first-page":"1","volume":"56","author":"LE Markowitz","year":"2007","unstructured":"Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1\u201324","journal-title":"MMWR Recomm Rep"},{"key":"5428_CR36","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1111\/cas.15482","volume":"113","author":"N Matsumura","year":"2022","unstructured":"Matsumura N, Tsunoda I (2022) Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine-induced disease. Cancer Sci 113:3313\u20133320. https:\/\/doi.org\/10.1111\/cas.15482","journal-title":"Cancer Sci"},{"key":"5428_CR37","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","volume":"65","author":"E Meites","year":"2016","unstructured":"Meites E, Kempe A, Markowitz LE (2016) Use of a 2-dose schedule for Human Papillomavirus Vaccination - updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 65:1405\u20131408. https:\/\/doi.org\/10.15585\/mmwr.mm6549a5","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5428_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1212\/WNL.0b013e31825fdead","volume":"79","author":"T Menge","year":"2012","unstructured":"Menge T, Cree B, Saleh A, Waterboer T, Berthele A, Kalluri SR et al (2012) Neuromyelitis optica following Human Papillomavirus vaccination. Neurology 79:285\u2013287. https:\/\/doi.org\/10.1212\/WNL.0b013e31825fdead","journal-title":"Neurology"},{"key":"5428_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic J, Arsenijevic A, Stojanovic B, Kanjevac T, Arsenijevic D, Radosavljevic G et al (2020) Interleukin-17 in chronic inflammatory neurological diseases. Front. Immunol. 11:947. https:\/\/doi.org\/10.3389\/fimmu.2020.00947","journal-title":"Front. Immunol."},{"key":"5428_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/erv.09.76","volume":"8","author":"A Monie","year":"2009","unstructured":"Monie A, Tsen SW, Hung CF, Wu TC (2009) Therapeutic HPV DNA vaccines. Expert Review of Vaccines 8:1221\u20131235. https:\/\/doi.org\/10.1586\/erv.09.76","journal-title":"Expert Review of Vaccines"},{"key":"5428_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02279","volume":"9","author":"VR Moulton","year":"2018","unstructured":"Moulton VR (2018) Sex hormones in acquired immunity and autoimmune disease. Front. Immunol. 9:2279. https:\/\/doi.org\/10.3389\/fimmu.2018.02279","journal-title":"Front. Immunol."},{"key":"5428_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28583","volume":"95","author":"K Naegele","year":"2023","unstructured":"Naegele K, Weissbach FH, Leuzinger K, Gosert R, Bubendorf L, Hirsch HH (2023) Impact of nucleic acid extraction procedures on Human Papillomavirus (HPV) detection and genotyping. J Med Virol 95:e28583. https:\/\/doi.org\/10.1002\/jmv.28583","journal-title":"J Med Virol"},{"key":"5428_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/pai.12762","volume":"28","author":"L Nilsson","year":"2017","unstructured":"Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E et al (2017) Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol 28:628\u2013640. https:\/\/doi.org\/10.1111\/pai.12762","journal-title":"Pediatr Allergy Immunol"},{"key":"5428_CR44","doi-asserted-by":"publisher","DOI":"10.25259\/CMAS_03_02_2021","volume":"19","author":"S Pimple","year":"2022","unstructured":"Pimple S, Mishra G (2022) Cancer cervix: epidemiology and disease burden. Cytojournal 19:21. https:\/\/doi.org\/10.25259\/CMAS_03_02_2021","journal-title":"Cytojournal"},{"key":"5428_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070115","volume":"379","author":"L Rahangdale","year":"2022","unstructured":"Rahangdale L, Mungo C, O\u2019Connor S, Chibwesha CJ, Brewer NT (2022) Human papillomavirus vaccination and cervical cancer risk. BMJ (Clinical research ed.) 379:e070115. https:\/\/doi.org\/10.1136\/bmj-2022-070115","journal-title":"BMJ (Clinical research ed.)"},{"key":"5428_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101460","volume":"54","author":"S Reza","year":"2024","unstructured":"Reza S, Anjum R, Khandoker RZ, Khan SR, Islam MR, Dewan S (2024) Public health concern-driven insights and response of low- and middle-income nations to the World Health Organization call for cervical cancer risk eradication. Gynecol Oncol Rep 54:101460. https:\/\/doi.org\/10.1016\/j.gore.2024.101460","journal-title":"Gynecol Oncol Rep"},{"key":"5428_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/SHK.0000000000001623","volume":"55","author":"JC Rincon","year":"2021","unstructured":"Rincon JC, Hawkins RB, Hollen M, Nacionales DC, Ungaro R, Efron PA et al (2021) Aluminum adjuvant improves survival via NLRP3 inflammasome and myeloid non-granulocytic cells in a murine model of neonatal sepsis. Shock 55:274\u2013282. https:\/\/doi.org\/10.1097\/SHK.0000000000001623","journal-title":"Shock"},{"key":"5428_CR48","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci 10:796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"key":"5428_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076302","volume":"24","author":"F Sciarra","year":"2023","unstructured":"Sciarra F, Campolo F, Franceschini E, Carlomagno F, Venneri MA (2023) Gender-specific impact of sex hormones on the immune system. Int J Mol Sci 24:076302. https:\/\/doi.org\/10.3390\/ijms24076302","journal-title":"Int J Mol Sci"},{"key":"5428_CR50","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cmi.2017.151","volume":"15","author":"Y Segal","year":"2018","unstructured":"Segal Y, Shoenfeld Y (2018) Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol 15:586\u2013594. https:\/\/doi.org\/10.1038\/cmi.2017.151","journal-title":"Cell Mol Immunol"},{"key":"5428_CR51","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.2169\/internalmedicine.55.5472","volume":"55","author":"K Sekiguchi","year":"2016","unstructured":"Sekiguchi K, Yasui N, Kowa H, Kanda F, Toda T (2016) Two cases of acute disseminated encephalomyelitis following vaccination against human papilloma virus. Intern Med 55:3181\u20133184. https:\/\/doi.org\/10.2169\/internalmedicine.55.5472","journal-title":"Intern Med"},{"key":"5428_CR52","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","volume":"33","author":"TT Shimabukuro","year":"2015","unstructured":"Shimabukuro TT, Nguyen M, Martin D, DeStefano F (2015) Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine 33:4398\u20134405. https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.035","journal-title":"Vaccine"},{"key":"5428_CR53","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1111\/cas.70213","volume":"116","author":"R Shiro","year":"2025","unstructured":"Shiro R, Sato F, Omura S, Park AM, Nguyen CT, Ahmad I et al (2025) Comparative cytokine and histology studies on HPV and other viral vaccinations: No pathogenicity of HPV vaccine adjuvants. Cancer Sci 116:3309\u20133325. https:\/\/doi.org\/10.1111\/cas.70213","journal-title":"Cancer Sci"},{"key":"5428_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000493737","volume":"63","author":"L Sichero","year":"2019","unstructured":"Sichero L, Giuliano AR, Villa LL (2019) Human Papillomavirus and genital disease in men: What we have learned from the HIM study. Acta Cytol 63:109\u2013117. https:\/\/doi.org\/10.1159\/000493737","journal-title":"Acta Cytol"},{"key":"5428_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071225","author":"A Stoian","year":"2023","unstructured":"Stoian A, Bajko Z, Stoian M, Cioflinc RA, Niculescu R, Arb\u0103na\u0219i EM et al (2023) The occurrence of acute disseminated encephalomyelitis in SARS-CoV-2 infection\/vaccination: Our experience and a systematic review of the literature. Vaccines Basel. https:\/\/doi.org\/10.3390\/vaccines11071225","journal-title":"Vaccines Basel"},{"key":"5428_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QCO.0b013e32834ed5be","volume":"25","author":"NW Stupiansky","year":"2012","unstructured":"Stupiansky NW, Alexander AB, Zimet GD (2012) Human papillomavirus vaccine and men: what are the obstacles and challenges. Curr Opin Infect Dis 25:86\u201391. https:\/\/doi.org\/10.1097\/QCO.0b013e32834ed5be","journal-title":"Curr Opin Infect Dis"},{"key":"5428_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1266067","volume":"14","author":"M Sun","year":"2023","unstructured":"Sun M, Liu H, Zhu B, Liu Y, Li A, Wang L (2023) Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis. Front Neurol 14:1266067. https:\/\/doi.org\/10.3389\/fneur.2023.1266067","journal-title":"Front Neurol"},{"key":"5428_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5428_CR59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mrc.5096","volume":"59","author":"MB Taraban","year":"2021","unstructured":"Taraban MB, Yu YB (2021) Monitoring of the sedimentation kinetics of vaccine adjuvants using water proton NMR relaxation. Magn Reson Chem 59:147\u2013161. https:\/\/doi.org\/10.1002\/mrc.5096","journal-title":"Magn Reson Chem"},{"key":"5428_CR60","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1080\/21645515.2015.1034914","volume":"11","author":"T Tay","year":"2015","unstructured":"Tay T, Agius C, Hamilton R, Bodle J, Rockman S (2015) Investigation into alternative testing methodologies for characterization of influenza virus vaccine. Hum Vaccin Immunother 11:1673\u20131684. https:\/\/doi.org\/10.1080\/21645515.2015.1034914","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR61","doi-asserted-by":"crossref","unstructured":"Villarroel\u00a0 MA, Galinsky AM, Lu PJ and Pingali C (2024) Human Papillomavirus Vaccination Coverage in Children Ages 9\u201317 Years: United States, 2022. NCHS data brief 1\u20138.","DOI":"10.15620\/cdc:145593"},{"key":"5428_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","volume":"471","author":"R Wang","year":"2020","unstructured":"Wang R, Pan W, Jin L, Huang W, Li Y, Wu D et al (2020) Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett 471:88\u2013102. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.039","journal-title":"Cancer Lett"},{"key":"5428_CR63","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41590-024-02059-6","volume":"26","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li R, Tong R, Chen T, Sun M, Luo L et al (2025) Integrating single-cell RNA and T cell\/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age. Nat Immunol 26:308\u2013322. https:\/\/doi.org\/10.1038\/s41590-024-02059-6","journal-title":"Nat Immunol"},{"key":"5428_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejpb.2018.07.019","volume":"131","author":"SR Wlodarczyk","year":"2018","unstructured":"Wlodarczyk SR, Cust\u00f3dio D, Pessoa A Jr, Monteiro G (2018) Influence and effect of osmolytes in biopharmaceutical formulations. Eur J Pharm Biopharm 131:92\u201398. https:\/\/doi.org\/10.1016\/j.ejpb.2018.07.019","journal-title":"Eur J Pharm Biopharm"},{"key":"5428_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05753-z","volume":"15","author":"N Yang","year":"2025","unstructured":"Yang N, Di J, Feng H (2025) Pharmacovigilance analysis of spondyloarthritis following HPV vaccination based on the VAERS database. Sci Rep 15:20023. https:\/\/doi.org\/10.1038\/s41598-025-05753-z","journal-title":"Sci Rep"},{"key":"5428_CR66","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","volume":"32","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xu H, Zhang L, Qiao Y (2020) Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 32:720\u2013728. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.06.05","journal-title":"Chin J Cancer Res"},{"key":"5428_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062505","author":"MY Zheng","year":"2025","unstructured":"Zheng MY, Luo LZ (2025) The role of IL-17A in mediating inflammatory responses and progression of neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26062505","journal-title":"Int J Mol Sci"},{"key":"5428_CR68","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.4161\/hv.28702","volume":"10","author":"F Zhu","year":"2014","unstructured":"Zhu F, Li J, Hu Y, Zhang X, Yang X, Zhao H et al (2014) Immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years. Hum Vaccin Immunother 10:1795\u20131806. https:\/\/doi.org\/10.4161\/hv.28702","journal-title":"Hum Vaccin Immunother"},{"key":"5428_CR69","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ygyno.2010.01.028","volume":"117","author":"GD Zimet","year":"2010","unstructured":"Zimet GD, Rosenthal SL (2010) HPV vaccine and males: issues and challenges. Gynecol Oncol 117:S26-31.","journal-title":"Gynecol Oncol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05428-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:07:18Z","timestamp":1784776038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05428-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5428"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05428-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}